Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 163,000 | 284,000 | 184,000 | 41,000 | 392,000 |
| Other Working Capital | -281,000 | -161,000 | -157,000 | 704,000 | -102,000 |
| Other Operating Activity | 1,391,000 | 643,000 | 900,000 | 1,442,000 | 1,787,000 |
| Operating Cash Flow | $1,273,000 | $766,000 | $927,000 | $2,187,000 | $2,077,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -292,000 | -266,000 | -192,000 | -351,000 | -310,000 |
| Net Acquisitions | -20,000 | 168,000 | -13,000 | 2,248,000 | -87,000 |
| Purchase Sale Intangibles | 77,000 | -72,000 | -140,000 | -101,000 | -141,000 |
| Other Investing Activity | 217,000 | 71,000 | 19,000 | 64,000 | 12,000 |
| Investing Cash Flow | $-216,000 | $-149,000 | $-334,000 | $1,828,000 | $-526,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 912,000 | 690,000 | -894,000 | 103,000 | 396,000 |
| Common Stock Issued | 11,000 | 32,000 | 81,000 | 91,000 | 68,000 |
| Common Stock Repurchased | -18,000 | -208,000 | -102,000 | -599,000 | -542,000 |
| Dividend Paid | -916,000 | -1,099,000 | -910,000 | -864,000 | -878,000 |
| Other Financing Activity | -169,000 | -368,000 | -764,000 | -348,000 | -147,000 |
| Financing Cash Flow | $-180,000 | $-953,000 | $-2,589,000 | $-1,617,000 | $-1,103,000 |
| Exchange Rate Effect | 64,000 | -39,000 | -2,000 | -73,000 | -136,000 |
| Beginning Cash Position | 2,858,000 | 3,233,000 | 5,231,000 | 2,906,000 | 2,594,000 |
| End Cash Position | 3,799,000 | 2,858,000 | 3,233,000 | 5,231,000 | 2,906,000 |
| Net Cash Flow | $877,000 | $-336,000 | $-1,996,000 | $2,398,000 | $448,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,273,000 | 766,000 | 927,000 | 2,187,000 | 2,077,000 |
| Capital Expenditure | -422,000 | -394,000 | -349,000 | -500,000 | -459,000 |
| Free Cash Flow | 851,000 | 372,000 | 578,000 | 1,687,000 | 1,618,000 |